It must be noted that rather than mutations in POMT2, those in FKRP are widely considered to cause the commonest dystroglycanopathy in Europe, LGMD2I [48]. This evidence concerns the gene FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.